The Market Access Society (MAS) is set to host the annual Market Access Day in Paris, a groundbreaking conference that unites healthcare experts, academics, industry leaders, and policy experts in shaping the future of market access. Held at the prestigious Sorbonne University, this event is a pivotal platform for participants to gain vital knowledge and connections in the dynamic healthcare landscape.
Key highlights of the conference include discussions on the long-awaited EU Health Technology Assessment (HTA), which is now gaining momentum, promising to redefine the HTA era in the EU. Additionally, sessions will explore the evolving trends in market access and how they are poised to disrupt traditional business models.
Regenerative medicine and Advanced Therapy Medicinal Products (ATMPs) will also take center stage, shedding light on the evolving market access rules and providing global insights into this transformative field. Furthermore, the conference will delve into the challenges facing the market access of oncology orphan drugs within the EU-HTA framework.
Artificial Intelligence’s (AI) impact on market access will be a key topic of discussion, examining how AI is poised to reshape various aspects of the pharmaceutical industry, from HTA to pricing and data analysis.
Lastly, the Inflation Reduction Act (IRA) in the United States will be explored, offering insights into the significant changes it brings to drug pricing and the potential implications for stakeholders.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
